Protalix Biotherapeutics, Inc. (PLX)
2.17
-0.04
(-1.81%)
USD |
NYAM |
Mar 19, 10:43
Protalix Biotherapeutics Shareholders Equity (Quarterly) : 48.23M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Denali Therapeutics, Inc. | 1.014B |
| Lisata Therapeutics, Inc. | 14.86M |
| OraSure Technologies, Inc. | 340.83M |
| Nephros, Inc. | 10.20M |
| Agenus, Inc. | -271.11M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 82.35M |
| Total Liabilities (Quarterly) | 34.12M |
| Debt to Equity Ratio | 0.1725 |
| Current Ratio | 2.514 |
| Net Debt Paydown Yield | -0.36% |